number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide GLP-1 prescription trends through June Google searches predicted surge in
Description
The next-generation therapy combines semaglutide with cagrilintide, a long-acting analog of amylin, which is a pancreatic peptide that lowers blood glucose levels and slows down gastric emptying
It's like your skin builds a protective wall
When glycogen is burned for energy, it releases water, which leads to weight loss
Orforglipron is the worlds second oral GLP-1 pill for weight management, approved by the FDA in April 2026
Adipose tissue (fat) acts as an endocrine organ, releasing inflammatory mediators that perpetuate both systemic inflammation and localized skin inflammation
